Month: January 2018

Biotech ETF stock chart

Did Black Swan Trump Strike Biotech Companies Again?


I can prove that President Trump was not the reason for the biotech sell-off on January 31, 2018.

Echostar Consolidation Ahead of Massive OneWeb Rollout


Shipments should begin in mid-2018 of OneWeb gateway equipment made by Echostar.

MasTec Stock Consolidation Setup On Rising Large Players Volume


MasTec stock has a compelling setup on a consolidation pattern during the first market pullback of 2018.

Currencies versus the US Dollar

A Falling US Dollar Is Pushing Stocks Up


The falling US dollar is putting a tail-wind behind stocks, but traders should track the dollar and be ready for this trend to reverse.

Monarch Casino and Resort Stock Basing On Exploding Large Players Volume


Monarch Casino and Resort stock is not a growth or value play but something is going on with the huge surge in large players volume.

Lam Research stock

Lam Research Looking Like A Good Setup


Lam Research has been one of my lagging stock picks pretty much doing nothing since October 2017 when I pushed out a research report. Now, the stock is looking like a good Buy the Dip set up. Lam Research posted its earnings results last week on January 24, 2018. The company reported EPS of $4.34 Read More »

Sell ABLX For a 27% Gain In 10 Trading Days!


Sanofi SA announced the acquisition of Ablynx NV at a price per Ablynx share of €45 in cash, which represents an aggregate equity value of approximately €3.9 billion. Shares of Ablynx closed up 13% to $53.65. Time for us to sell and book a 27% gain in just 10 trading days since I pushed out Read More »

Which Stock Should I Trade With Only $2,000 In My Trading Account?


A common question I get asked by Premium members is which stock should be traded when the next trade absolutely has to be a winning trade. The answer is you want to trade a quality stock, not a riskier growth stock. About 80% of all stocks in the various portfolios will beat on their next Read More »

Antares Pharma Stock

Antares Pharma PDUFA On Rising Large Players Volume


Antares Pharma has had a few set backs over the years and investors have waited patiently for the company to turn a profit.

The number of clinical trials is exploding higher.

BioLife Solutions and SAVSU Technologies Expand Partnership


BioLife Solutions stock is in a Symmetrical Triangle pattern as the company makes big moves in the biotechnology shipping container space.